HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Wu Selected Research

TCF Transcription Factors

1/2010IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.
6/2003Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
6/2002Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
4/2002Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.
3/2002ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Wu Research Topics

Disease

74Neoplasms (Cancer)
10/2022 - 03/2002
17Carcinoma (Carcinomatosis)
10/2022 - 08/2002
16Inflammation (Inflammations)
01/2022 - 11/2011
13Breast Neoplasms (Breast Cancer)
01/2022 - 04/2013
12Hypertension (High Blood Pressure)
11/2011 - 01/2002
11Fibrosis (Cirrhosis)
08/2022 - 02/2010
10Liver Cirrhosis (Hepatic Cirrhosis)
08/2022 - 10/2006
10Endometrioid Carcinoma
01/2020 - 04/2002
9Carcinogenesis
12/2020 - 01/2011
8Insulin Resistance
11/2022 - 07/2002
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2012
8Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2010
7Obesity
11/2022 - 01/2015
7Neoplasm Metastasis (Metastasis)
10/2019 - 06/2012
7Ovarian Neoplasms (Ovarian Cancer)
07/2015 - 08/2002
7Papilloma (Papillomatosis)
03/2012 - 02/2002
6Crohn Disease (Crohn's Disease)
11/2022 - 04/2013
6Colonic Neoplasms (Colon Cancer)
01/2019 - 04/2002
6Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2015 - 03/2002
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 03/2002
5Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2014
5Adenocarcinoma
01/2021 - 08/2002
5Infections
01/2021 - 03/2002
5Parkinson Disease (Parkinson's Disease)
01/2020 - 10/2012
5Lung Neoplasms (Lung Cancer)
10/2019 - 09/2012
5Melanoma (Melanoma, Malignant)
01/2017 - 01/2013
5Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 04/2004
4Body Weight (Weight, Body)
06/2022 - 06/2005
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2022 - 10/2014
4Hypoxia (Hypoxemia)
01/2022 - 01/2016
4Hemorrhage
11/2021 - 03/2012
4Hyperthermia
01/2021 - 01/2019
4Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2011
4Adenocarcinoma of Lung
10/2019 - 09/2002
4Cardiomegaly (Heart Hypertrophy)
02/2018 - 06/2005
3Heart Failure
01/2022 - 03/2009
3Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 07/2015
3Respiratory Insufficiency (Respiratory Failure)
01/2022 - 02/2018
3Premature Birth (Birth, Premature)
01/2021 - 11/2016
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 01/2015
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 09/2014
3Sepsis (Septicemia)
10/2019 - 12/2015

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
13Biomarkers (Surrogate Marker)IBA
08/2022 - 11/2006
12Glucose (Dextrose)FDA LinkGeneric
11/2022 - 07/2002
11MicroRNAs (MicroRNA)IBA
01/2019 - 01/2013
10Pharmaceutical PreparationsIBA
03/2021 - 09/2007
10Angiotensin IIIBA
11/2013 - 01/2002
9Therapeutic UsesIBA
08/2022 - 01/2013
9Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 01/2010
8DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2002
8beta CateninIBA
01/2010 - 03/2002
7Messenger RNA (mRNA)IBA
10/2020 - 03/2002
7Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2015 - 06/2005
6Biological ProductsIBA
01/2022 - 08/2002
6AntioxidantsIBA
01/2022 - 10/2004
6Insulin (Novolin)FDA Link
07/2021 - 07/2002
6Superoxides (Superoxide)IBA
01/2012 - 07/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2013
5RNA (Ribonucleic Acid)IBA
01/2022 - 09/2008
5CollagenIBA
12/2021 - 12/2012
5Small Interfering RNA (siRNA)IBA
01/2021 - 11/2010
5Long Noncoding RNAIBA
01/2021 - 01/2018
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 03/2003
5EnzymesIBA
06/2019 - 01/2011
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2012 - 07/2002
5TCF Transcription FactorsIBA
01/2010 - 03/2002
4LipopolysaccharidesIBA
11/2022 - 10/2014
4GadoliniumIBA
02/2022 - 10/2020
4NF-kappa B (NF-kB)IBA
01/2022 - 02/2002
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021 - 03/2012
4CateninsIBA
01/2021 - 03/2008
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2011
4CytokinesIBA
01/2021 - 01/2019
4AdiponectinIBA
12/2020 - 12/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
09/2018 - 05/2015
4AngiotensinsIBA
10/2014 - 10/2004
4Hemostatics (Antihemorrhagics)IBA
07/2013 - 03/2012
4Phosphotransferases (Kinase)IBA
02/2012 - 03/2003
4Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
12/2008 - 03/2002
3xiaoyaosanIBA
08/2022 - 01/2021
3Oxygen (Dioxygen)IBA
06/2022 - 07/2016
3Epidermal Growth Factor (EGF)IBA
01/2022 - 09/2005
3PlatinumIBA
01/2022 - 01/2013
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
3ChemokinesIBA
01/2022 - 12/2015
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021 - 09/2005
3Hormones (Hormone)IBA
12/2020 - 03/2005
3Ursolic AcidIBA
01/2020 - 01/2014
3Blood Glucose (Blood Sugar)IBA
11/2019 - 11/2012
3triptolideIBA
06/2019 - 12/2013

Therapy/Procedure

32Therapeutics
10/2022 - 10/2004
12Radiotherapy
07/2021 - 03/2009
10Drug Therapy (Chemotherapy)
01/2022 - 01/2012
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 09/2007
5Chemoradiotherapy
01/2022 - 06/2012
4Precision Medicine
03/2021 - 12/2017
4Transplantation
01/2021 - 01/2011
3Interactive Ventilatory Support
06/2022 - 10/2014
3Microbubbles
03/2021 - 01/2020